Skip to main content

Exforge HCT FDA Approval History

FDA Approved: Yes (First approved April 30, 2009)
Brand name: Exforge HCT
Generic name: amlodipine, valsartan and hydrochlorothiazide
Dosage form: Tablets
Company: Novartis AG
Treatment for: High Blood Pressure

Exforge HCT is a combination of the calcium channel blocker amlodipine, the angiotensin receptor blocker valsartan, and the diuretic hydrochlorothiazide indicated for the once-daily combination treatment of hypertension.

Development timeline for Exforge HCT

Apr 30, 2009Approval FDA approves Exforge HCT - the only high blood pressure treatment to combine three medications in a single pill

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.